Genitourinary Cancers Symposium Media Resource Center

Embargo Policy

The embargo on all abstracts part of the 2016 Genitourinary Cancers Symposium will lift at 5:00 PM ET on Monday, January 4, 2016. An embargoed presscast (virtual press briefing held via teleconference and webinar) will be held at 12:00 noon ET on January 4 for credentialed media.

Attend the Meeting in Person/Participate in the Presscast

ASCO's Media Headquarters is where you can apply for media credentials*, register to attend an upcoming meeting, access embargoed meeting information, and locate presscast dial-in information. For questions about how to navigate the site, please contact mediaregistration@asco.org.

*If you attended the 2015 ASCO Annual Meeting or covered the meeting remotely, you have already been credentialed by ASCO and will have access to the embargoed meeting information and the presscast. You only have to register if you want to attend the Symposium in San Francisco. 

Media Registration and Housing Instructions

2016 Genitourinary Cancers Symposium Media Policies

Access Embargoed Information

Embargoed meeting information will be made available to credentialed media through ASCO's Media Headquarters. Once your media credentials are approved, you will receive email notifications when embargoed information has been posted.

Press Releases

2016 Symposium Highlights Notable Research Advances in Genitourinary Cancers
SAN FRANCISCO - Eight studies exploring key issues in the treatment of genitourinary cancers will be presented at the 2016 Genitourinary Cancers Symposium, taking place January 7-9 at the Moscone West Building in San Francisco. Read the full release.

Cabozantinib Improves Upon the Standard of Care for Advanced Kidney Cancer
ALEXANDRIA, Va. – New analyses from a phase III clinical trial of patients with previously treated advanced kidney cancer demonstrated that patients of all risk levels experience more benefit from cabozantinib than from the current standard of care everolimus. Read the full release.

Regular Aspirin Use May Reduce Risk of Dying From Prostate Cancer
ALEXANDRIA, Va. – A large observational study has found that men who take aspirin regularly may have a lower risk of dying from prostate cancer. Read the full release.

New Blood Test Technology Shows Promise for Guiding Prostate Cancer Treatment Decisions
ALEXANDRIA, Va. – An early study suggests that an experimental new blood test may help guide individualized decisions on the most appropriate treatments for patients with prostate cancer. Read the full release.

2016 Genitourinary Cancers Symposium Press Program to Feature Research Advances in Prostate and Kidney Cancers
ALEXANDRIA, Va. – Co-sponsors of the 2016 Genitourinary Cancers Symposium announced today three abstracts that will be highlighted in the meeting’s official Press Program. Read the full release.

View the January 4 Presscast Recording

View a recording of the January 4 presscast, featuring three studies from the upcoming 2016 Genitourinary Cancers Symposium.

ON-SITE INFORMATION

On-site information for press, including press room hours, location, etc.

Meeting Information

Media Resources

  • ASCO Photo Gallery
  • Cancer.Net: Celebrating 10 years of helping patients! Oncologist-approved patient information
  • CancerProgress.Net: Interactive and downloadable charts and timelines and historical commentary on the progress against cancer

How Can We Help You?

Interview Requests
mediateam@asco.org
Please do not send media registration requests to this email address.

Media Registration Questions
mediaregistration@asco.org

General Questions About the Meeting
Kelly Baldwin, kelly.baldwin@asco.org
Alise Fisher, alise.fisher@asco.org